Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lake

Showing results (251-260 of 292) with videos related to

Pageof 30
Sort By:
Toxicology and Applied Pharmacology|February 9, 2013
Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver diseaseApril D Lake, Petr Novak, Petia Shipkova, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990
Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitroW E Robinson, T Kawamura, M K Gorny, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 16, 2012
Altered arsenic disposition in experimental nonalcoholic fatty liver diseaseMark J Canet, Rhiannon N Hardwick, April D Lake, et al.
Medical Physics|March 1, 1978
An automated dosimetry data-acquisition and analysis system at the LAMPF pion therapy facilityI Rosen, A Smith, R Lane, et al.
Transplantation Proceedings|March 27, 2001
Time to first graft loss as a risk factor for second renal allograft lossJ A Arndorfer, H U Meier-Kriesche, A O Ojo, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 9, 2002
Safety and efficacy of atorvastatin in heart transplant recipientsDevang N Patel, Francis D Pagani, Todd M Koelling, et al.
Amino Acids|December 24, 2014
Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver diseaseApril D Lake, Petr Novak, Petia Shipkova, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
The pharmacological profile of (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a selective 5-hydroxytryptamine(1A) receptor agonistL Rënyi, J L Evenden, C J Fowler, et al.
American Journal of Medical Genetics|February 15, 1992
Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease)D N Palmer, I M Fearnley, J E Walker, et al.
General Pharmacology|July 1, 1995
Chronic manipulation of dietary salt modulates renal physiology and kidney dopamine receptor subtypes: functional and autoradiographic studiesN A Sharif, J L Nunes, K D Lake, et al.
Pageof 30

Showing results (251-260 of 292) with videos related to

Sort By:
Pageof 30
Toxicology and Applied Pharmacology|February 9, 2013
Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver diseaseApril D Lake, Petr Novak, Petia Shipkova, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990
Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitroW E Robinson, T Kawamura, M K Gorny, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 16, 2012
Altered arsenic disposition in experimental nonalcoholic fatty liver diseaseMark J Canet, Rhiannon N Hardwick, April D Lake, et al.
Medical Physics|March 1, 1978
An automated dosimetry data-acquisition and analysis system at the LAMPF pion therapy facilityI Rosen, A Smith, R Lane, et al.
Transplantation Proceedings|March 27, 2001
Time to first graft loss as a risk factor for second renal allograft lossJ A Arndorfer, H U Meier-Kriesche, A O Ojo, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 9, 2002
Safety and efficacy of atorvastatin in heart transplant recipientsDevang N Patel, Francis D Pagani, Todd M Koelling, et al.
Amino Acids|December 24, 2014
Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver diseaseApril D Lake, Petr Novak, Petia Shipkova, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
The pharmacological profile of (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a selective 5-hydroxytryptamine(1A) receptor agonistL Rënyi, J L Evenden, C J Fowler, et al.
American Journal of Medical Genetics|February 15, 1992
Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease)D N Palmer, I M Fearnley, J E Walker, et al.
General Pharmacology|July 1, 1995
Chronic manipulation of dietary salt modulates renal physiology and kidney dopamine receptor subtypes: functional and autoradiographic studiesN A Sharif, J L Nunes, K D Lake, et al.
Pageof 30